NDC 49035-433-12 - Headache Relief Extra Strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49035-433
- Requested NDC
- 49035-433-12
- Package NDCs from labels
- 49035-433-08, 49035-433-85, 49035-433-12, 49035-433-06
- Manufacturer
- Wal-Mart Stores Inc | LNK International, Inc.
- Effective date
- 2026-06-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Equate 44-334B | Wal-Mart Stores Inc | LNK International, Inc. | 2026-06-30 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49035-433-06 | Headache ReliefExtra Strength | 2 in 1 CARTON | TABLET, FILM COATED | 2 | 17 | |
| 49035-433-08 | Headache ReliefExtra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 17 | |
| 49035-433-08 | Headache ReliefExtra Strength | 24 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 24 | 17 | |
| 49035-433-12 | Headache ReliefExtra Strength | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 17 | |
| 49035-433-85 | Headache ReliefExtra Strength | 200 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 200 | 17 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49035-433 | HEADACHE RELIEF EXTRA STRENGTH (ACETAMINOPHEN, ASPIRIN AND CAFFEINE) TABLET, FILM COATED [WAL-MART STORES INC] | 16 | Current NDC, Legacy NDC, 5 package rows | 20250501_9b1201af-c802-4e19-b192-bbbf34367db4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49035-433-06 | EA - Each | 49035-433 | 733cc245-97e9-47ca-84a4-cd7448ce0734 | 1 | 2024-04-05 |
| 49035-433-08 | EA - Each | 49035-433 | 110860f9-5ace-49e2-b01c-da9c7062a828 | 1 | 2019-08-06 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Combogesic | ACETAMINOPHEN AND IBUPROFEN | Preferred Pharmaceuticals Inc. | f3cee991-19ef-4a1c-bb14-cbc8b6f32776 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| equate aspirin | ASPIRIN | Wal-Mart Stores Inc | ea3f8eed-7b70-4156-9586-125d27bf29a8 | 2026-08-19 | Warnings | M013 R16CO5Y76E |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | ACETAMINOPHEN AND CODEINE PHOSPHATE | REMEDYREPACK INC. | 5c96d033-bf7c-47de-aa0d-5998b3bf4a63 | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| aspirin chewable, low dose | ASPIRIN | United Natural Foods, Inc. dba UNFI | 6a6ac7fe-91a4-4b55-979a-b53b51505d8b | 2026-08-19 | Warnings | M013 R16CO5Y76E |
| Pain Relief PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Strategic Sourcing Services LLC | b3baf939-a9fd-47ac-9bc7-68435e32ea1e | 2026-08-19 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Sam's West Inc | 1098d0e7-8202-4018-a2d2-b0c80ee58b56 | 2026-08-19 | Warnings | M013 362O9ITL9D |
| CVS Childrens Cold plus Cough plus Runny Nose | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND DEXTROMETHORPHAN HYDROBROMIDE | CVS | 7dc30e46-e289-40fc-b217-b123fee5daee | 2026-08-19 | Warnings | 362O9ITL9D |
| nighttime severe cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Amazon.com Services LLC | 2517b241-c433-440f-999d-5a32d5bbaa26 | 2026-08-19 | Warnings | 362O9ITL9D |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Safeway, Inc. | 5e77dca4-2ff8-4a8c-94bd-f224b680ca23 | 2026-08-19 | Warnings | M013 308297 3G6A5W338E R16CO5Y76E 362O9ITL9D |
| dg health pain relief pm extra strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Dolgencorp Inc | 4d1eddf0-eff7-4c47-b312-30dee08d9e5f | 2026-08-19 | Warnings | M013 362O9ITL9D |
| CareOne 8 Hour Pain Relief | ACETAMINOPHEN | American Sales Company | 9b2b0ef0-7071-4536-8f74-8f1d6250e105 | 2026-08-19 | Warnings | 362O9ITL9D |
| CVS Maximum Strength Cold and Flu Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN ,PHENYLEPHRINE HCL | CVS PHARMACY | e1c246a4-7a8c-4761-ab26-13b5165029cc | 2026-08-19 | Warnings | 362O9ITL9D |
| CVS Childrens Nighttime Multi Symptom Cold | ACETAMINOPHEN , DIPHENHYDRAMINE HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE | CVS PHARMACY | 9b244ac8-4ca7-43a0-b328-88f15f0fcc9d | 2026-08-19 | Warnings | 362O9ITL9D |
| Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg | ASPIRIN AND EXTENDED - RELEASE DIPYRIDAMOLE | Major Pharmaceuticals | a6e652e1-b2e4-47ba-bed2-c5e902f8b8f1 | 2026-08-19 | Warnings, Adverse reactions | R16CO5Y76E |
| CVS Severe Congestion and Pain Relief | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CVS | 5a8e4320-bae1-4831-b66b-9babfe8888d6 | 2026-08-19 | Warnings | 362O9ITL9D |
| CVS Severe Tussin CF Max | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | CVS PHARMACY | e32881f5-2bb5-4756-aa86-a09473ab590b | 2026-08-19 | Warnings | 362O9ITL9D |
| Headache Formula Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | ARMY AND AIR FORCE EXCHANGE SERVICE | ee8d0961-7572-471f-8c96-b4c0bd354de2 | 2026-08-18 | Warnings | M013 308297 3G6A5W338E R16CO5Y76E 362O9ITL9D |
| CVS Daytime Cold and Flu Relief | ACETAMINOHPEN, DEXTROMETHORPHAN HBR, GUAIFENESIN PHENYLEPHRINE HCL | CVS PHARMACY | 558b7ed6-a9f6-452c-90cd-df8258663bf1 | 2026-08-18 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Rugby Laboratories | 76f10ee2-1d6a-097c-e053-2991aa0af526 | 2026-08-18 | Warnings | M013 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Major Pharmaceuticals | 780aad35-d0f1-44b1-e053-2991aa0af9a7 | 2026-08-18 | Warnings | M013 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.